Diagnosis and relapse: cytogenetically normal acute myelogenous leukemia without FLT3-ITD or MLL-PTD

Leukemia. 2017 Mar;31(3):762-766. doi: 10.1038/leu.2016.343. Epub 2016 Nov 24.

W Chien¹, Q-Y Sun¹, L-W Ding¹, A Mayakonda¹, S Takao¹, L Liu¹, S L Lim¹, K T Tan¹, M Garg¹, A De Sousa Maria Varela¹, J Xiao¹, N Jacob¹, K Behrens², C Stocking², M Lill^{3

4}, V Madan¹, N Hattori¹, S Gery^{3

4}, S Ogawa⁵, S Wakita⁶, T Ikezoe⁷, L-Y Shih⁸, T Alpermann⁹, T Haferlach⁹, H Yang¹, H P Koeffler^{1

3

4

10}

¹ Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore.
² Heinrich Pette Institute, Hamburg, Germany.
³ Department of Hematology-Oncology, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
⁴ Department of Medicine, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA.
⁵ Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
⁶ Department of Internal Medicine, Division of Hematology, Nippon Medical School, Tokyo, Japan.
⁷ Department of Hematology and Respiratory Medicine, Kochi Medical School, Kochi University, Nankoku, Japan.
⁸ Department of Internal Medicine, Division of Hematology-Oncology, Chang Gung Memorial Hospital, Chang Gung University, Taipei, Taiwan.
⁹ MLL Munich Leukemia Laboratory, Munich, Germany.
¹⁰ National University Cancer Institute, National University Hospital, Singapore, Singapore.

No abstract available

Publication types